Abstract | AIM OF THE STUDY: MATERIALS AND METHODS: Two protocols were designed for administration of SQC-beta-CD (10 and 20 mg/kg body weight) or DEX (2 mg/kg). According to Protocol A we intraperitoneally injected diluent (saline with 0.5% Tween 80), SQC-beta-CD or DEX respectively into mice 30 min and 3h after LPS challenge. Alternatively, in Protocol B we administered diluent, SQC-beta-CD or DEX 3h before and 30 min after LPS challenge. RESULTS: The histological results showed that SQC-beta-CD (20 mg/kg) protected mice from LPS-induced ALI such as oedema, haemorrhage, blood vessel and alveolar structural damage. Furthermore, SQC-beta-CD inhibited LPS-increased pulmonary MPO activity and migration of polymorphonuclear neutrophils (PMNs) into bronchoalveolar lavage fluid (BALF). Immunohistochemical experiment demonstrated that SQC-beta-CD decreased inducible nitric oxide synthase (iNOS) expression in lung 24h after LPS administration. Consequently, SQC-beta-CD prevented LPS-induced nitric oxide (NO) release in BALF. CONCLUSIONS: The results indicated that SQC-beta-CD is greatly effective in inhibiting ALI. The present study indicated that SQC-beta-CD acted as a potential therapeutic reagent for treating ALI.
|
Authors | Qin Feng, Yong Ren, Yu Wang, Hsiaoyen Ma, Jun Xu, Chenrong Zhou, Zhimin Yin, Lan Luo |
Journal | Journal of ethnopharmacology
(J Ethnopharmacol)
Vol. 118
Issue 1
Pg. 51-8
(Jun 19 2008)
ISSN: 0378-8741 [Print] Ireland |
PMID | 18495394
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Inflammatory Agents
- Drugs, Chinese Herbal
- Lipopolysaccharides
- Plant Extracts
- beta-Cyclodextrins
- Nitric Oxide
- Dexamethasone
- Nitric Oxide Synthase Type II
- betadex
|
Topics |
- Animals
- Anti-Inflammatory Agents
(administration & dosage, pharmacology)
- Dexamethasone
(pharmacology)
- Dose-Response Relationship, Drug
- Drugs, Chinese Herbal
(administration & dosage, chemistry, pharmacology)
- Lipopolysaccharides
- Male
- Mice
- Mice, Inbred ICR
- Nitric Oxide
(metabolism)
- Nitric Oxide Synthase Type II
(drug effects, metabolism)
- Plant Extracts
(administration & dosage, chemistry, pharmacology)
- Respiratory Distress Syndrome
(chemically induced, drug therapy, physiopathology)
- Time Factors
- beta-Cyclodextrins
(chemistry)
|